Skip to main content

Table 2 Clinicopathological features of the patients with LMS (n = 37)

From: miRNAs 144-3p, 34a-5p, and 206 are a useful signature for distinguishing uterine leiomyosarcoma from other smooth muscle tumors

Feature

Categories

No. cases (%)

Patient age

≤ 50 years

19 (51.0)

> 50 years

18 (49.0)

Clinical stage

I

10 (27.0)

II

10 (27.0)

III

5 (13.5)

IV

12 (32.5)

Relapse

No

6 (16.0)

Yes

27 (73.0)

NAa

4 (11.0)

Metastasis

Locoregional

12 (32.0)

Distant

15 (41.0)

Absent/NA

10 (27.0)

Treatment

Surgery alone

10 (27.0)

Radiotherapy

11 (29.7)

Chemotherapy

11 (29.7)

Patient status

Surviving

7 (18.9)

Dead

26 (70.3)

Loss of follow-up/NA

4 (10.8)

  1. aNA: not available